Critical Issues in the Treatment of CoOccurring Disorders - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

Critical Issues in the Treatment of CoOccurring Disorders

Description:

Supported by the National Institute on Drug Abuse grant K23 DA15144 (MVP) ... gift for research from the Mohegan Sun casino; and 4) Women's Health Research at Yale ... – PowerPoint PPT presentation

Number of Views:34
Avg rating:3.0/5.0
Slides: 24
Provided by: desktoptec
Category:

less

Transcript and Presenter's Notes

Title: Critical Issues in the Treatment of CoOccurring Disorders


1
Critical Issues in the Treatment of Co-Occurring
Disorders
  • Michael V. Pantalon, Ph.D.
  • Assistant Professor of Psychiatry
  • Yale University School of Medicine
  • Supported by the National Institute on Drug Abuse
    grant K23 DA15144 (MVP).

2
What are the critical issues?
  • Integrated Assessment Rx Services
  • primarily concerned with SMI Substance Abuse
  • Motivational Factors
  • Engagement Adherence
  • Pharamcologic Aspects
  • The Self-Medication Hypothesis
  • Other types of CODs

3
Integrated Assessment Treatment Services
  • Who do we fail to screen?
  • Assessing depression in opiate dependence
  • Which came 1st does it always matter?
  • Non- sub-syndromal aspects
  • demoralization, levels of recreational gambling
  • Integrated services gt non-integrated
  • But no one combination of Rx superior to any
    other
  • Logistically difficult
  • Requires highly trained or supervised staff

4
Depression Adherence in Cocaine Opioid
Dependence
  • In 2 RCTs, agonist-maintained pts with persistent
    depressive sx (BDIgt16 at intake 1 month later)
    were significantly less likely to
  • complete treatment (58 vs. 80, plt.05) or
  • achieve 3 or more consecutive weeks of abstinence
    from illicit opioids (19 vs. 49, plt0.01) or
    cocaine (38 vs. 59, p0.08).

5
Motivational Factors
  • Client-centered vs. services delivery focus
  • Treatment focus, ordering, emphasis
  • Treatment modifications based on motivation are
    ok even empirically validated
  • Stage-wise approach harm reduction Double
    Trouble groups
  • Motivational assessments
  • Motivational interventions
  • Motivational Interviewing for co-occurring
    disorders

6
Improving Adherence with Motivational Interviewing
  • Standard Treatment (ST)MI gt ST for increasing
    o/p treatment adherence in inpt psych DD pts
  • Overall, 47 vs. 21 attended 1st o/p appt.
  • for dually-diagnosed patients, 42 for STMI
    versus 16 for ST
  • Similar results for psychotic affective
    disorders

7
Motivation Adherence
  • Based on the URICA, Low (vs. High) Readiness to
    change psych DD patients attended a greater
    proportion of
  • inpt. CBT groups (54 vs. 39, plt.05) and
  • clinic appointments during their first month
    post-discharge (77 vs. 53, plt.05).
  • Low Readiness pts were also more likely to have
    perfect attendance in their 1st month
    post-discharge (26 vs. 10, plt.05).
  • No sig intx w/treatment condition
  • Motivation Disulfiram outcomes

8
Predictors of treatment adherence during
motivational interviewing for co-occurring
disorders
  • Michael V. Pantalon, Ph.D.
  • Declan T. Barry, Ph.D.
  • Yale University School of Medicine
  • Arthur J. Swanson, Ph.D.
  • Albert Einstein Medical College
  • Supported by the National Institute on Drug Abuse
    grant K23 DA15144 (MVP).

9
Table 2 Predictors of Adherence to the First
Scheduled Appointment Post-Discharge
10
Table 2 (contd) Predictors of the First
Scheduled Appointment Post-Discharge
11
Table 2 (contd) Predictors of Adherence to the
First Scheduled Appointment Post-Discharge
12
Figure 1
13
Figure 2
14
Engagement Adherence
  • Focus on motivational outreach engagement Rx
    on demand
  • New line of studies
  • Data emerging
  • Our initial studies focus on medication adherence

15
Pharmacologic Issues
  • Co-occurring pharmacologic Rx
  • double-duty
  • Which came first does it always matter?
  • Antidepressants for illicit drug dependence
  • Effective meds for single psych may NOT be
    effective for CODs (see table Drake et al.,
    2003)
  • Substance Abuse Rx communitys misconceptions re
    meds

16
Treatment of depression in methadone maintained
patientsNunes EV, Archives General Psychiatry
55153-160, 1998
17
Treatment of depressionEffects on illicit drug
useNunes EV, Archives General Psychiatry
55153-160, 1998
18
Self-Medication Hypothesis
  • Self-Medication PT I use cocaine to deal with
    my depression
  • vs. the Abstinence 1st viewpoint TX All
    cocaine other drug use must end BEFORE any
    depression Rx begins.
  • implying that the substance abuse caused the
    psychiatric problems
  • Which is it?
  • Underlying traits/capabilities vs diagnoses

19
The co-occurrence of recreational gambling
substance abuse Do the motivations to gamble
make a difference?
  • Michael V. Pantalon, Paul K. Maciejewski, Rani A.
    Desai, Marc N. Potenza
  • Supported in part by 1) NIDA grants K23-DA15144
    (MVP), K12-DA00167 (MNP), and K12-DA0366 (MNP)
    2) the National Center for Responsible Gaming 3)
    an unrestricted gift for research from the
    Mohegan Sun casino and 4) Womens Health
    Research at Yale

20
Excitement-seeking, Gambling, Impulse Control
  • Excitement, gambling, and diminished impulse
    control appear linked, although the relationship
    is incompletely understood.
  • Theories have been advanced to explain the
    relationship between excitement- or
    sensation-seeking and gambling.
  • Gambling is reinforced by the positive emotional
    sensations, arousal, or excitement which it is
    associated
  • The need for excitement/arousal or a high
    susceptibility to boredom will lead to impulsive
    excitement/sensation-seeking
  • Gambling and other addictive behaviors share
    common underlying biological mechanism implicated
    in impulsivity, a component of sensation seeking
  • Intermediate factors in the relationship between
    excitement- or sensation-seeking and gambling
  • Sensation-seeking-induced gambling can lead to
    drug and alcohol abuse in an attempt to relieve
    anxiety or depression following large gambling
    losses, or an attempt to celebrate or further
    enhance the sensation of excitement in the case
    of large wins

21
Table 2 Psychosocial Functioning Measures in
Excitement-Seeking and Non-Excitement-Seeking
Recreational Gamblers
22
Other Types of CODs
  • COD pts in SA Rx cntr vs those in CMHCs
  • Opiate Dependence
  • chronic medical problems (e.g., Bup in PC)
  • SPMI ? Low access to agonist maintenance
  • Substance Abuse Pain
  • Substance Abuse Anxiety Disorders
  • under-diagnosed
  • under-treated
  • over-reliance on benzos/under-reliance on SSRIs
    CBT (ESTs for anxiety dx-e.g., see JAMA 10/27/04)
  • benzo use is controversial

23
CONCLUSIONS
  • Screen, screen, screen
  • Integrate sa psych Rx
  • Dont get too caught up in which came 1st
  • Assess motivation with Readiness Ruler,On a
    scale of 1-10, how ready are you to? ANSWhy
    not less?
  • Utilize brief MI other client-centered
    approaches
  • Adherence often much more important than specific
    Rx
  • However, select meds carefully when clear COD
    (see Drake et al. guidelines)
  • Consider non-traditional CODs
  • Consider underlying pt capabilities/traits that
    may explain vulnerability to relapse/sx
    exacerbation across all dx
  • Keep in mind staff attitudes
  • COD requires Co-Occurring Rx
  • Pass the word along
Write a Comment
User Comments (0)
About PowerShow.com